Demonstrates δ-amastin regulation in Leishmania, implying new insights into pathogenicity.
Unicellular Leishmania parasites cause leishmaniases and require a life cycle stage-specific surface coat for pathogenesis. A major protein component of this coat is δ-amastins, which are human infective amastigote life cycle stage-specific transmembrane glycoproteins. Leishmania genes are encoded in co-transcribed gene arrays with little gene-specific transcriptional control. Here, we show that the Leishmania mexicana ortholog of ESB1, a nuclear protein we previously identified in the related parasite, Trypanosoma brucei, is required for δ-amastin regulation. LmxESB1 localises to a promastigote-specific nuclear body and its deletion caused derepression of δ-amastin expression from specific chromosomal loci. This upregulated δ-amastin phenotype was unstable, recovering over time. Transcriptomic analysis of recovered mutants identified two additional factors: LmxM.34.0190, an NIF-like phosphatase NIFP1, and LmxM.23.0730, the RNA-binding protein RBP10. Deletion of which also result in δ-amastin misexpression. We have therefore identified a novel Leishmania nuclear protein that contributes to δ-amastin repression in promastigotes and factors that act in parallel with LmxESB1. This expands our understanding of how Leishmania controls stage-specific gene expression of surface coat proteins necessary for pathogenicity.
No takes yet. Share an insight, caveat, or question.
Angel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: